Ascentage Pharma’s Lisaftoclax Granted Breakthrough Therapy Designation in China for Treatment-Naïve CLL/SLL

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, ...

Laxxon Medical to Participate in the Jefferies Global Healthcare Conference

Laxxon Medical Corp. ("Laxxon Medical" or the "Company"), a pharmaceutical technology company developing advanced drug delivery solutions through its proprietary SPID® (Screen Printed Innovative Drugs ...
BIG on MSN

As AI faces growing controversy and bubble fears, scientists administer first AI-designed virus to human patient

Scientists have administered an AI-designed virus to a human patient for the first time, marking a medical breakthrough as ...
EuropaWire

LANXESS unveils Rely+On Medero disinfectant for medical devices and healthcare surfaces

LANXESS offers Rely+On Medero in different packaging sizes: The single-dose format in 20- or 40-gram sachets allows the product to be dosed easily and is supported by a clear dosing table. The product ...
RTTNews

Sisram Advances Profhilo In China As NMPA Accepts Filing

Sisram Medical Ltd. (1696.HK), a medical aesthetics company offering energy-based devices, injectables, and other solutions, announced that China's National Medical Products Administration (NMPA) has ...